KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 3 filers reported holding KALA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $14,000 | -36.4% | 64,873 | -13.1% | 0.00% | -50.0% |
| Q2 2022 | $22,000 | -88.7% | 74,636 | -46.9% | 0.00% | -85.7% |
| Q1 2022 | $194,000 | +26.8% | 140,511 | +11.3% | 0.01% | -12.5% |
| Q4 2021 | $153,000 | +13.3% | 126,231 | +884.9% | 0.02% | 0.0% |
| Q2 2020 | $135,000 | +55.2% | 12,816 | -45.5% | 0.02% | +100.0% |
| Q4 2019 | $87,000 | -56.5% | 23,500 | +15.7% | 0.01% | -33.3% |
| Q3 2018 | $200,000 | – | 20,310 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |